Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells

被引：2

作者：

Zhang, Li ^{[1
]}

Li, Xia ^{[2
]}

Xu, Xintian ^{[3
]}

Le, Yunchen ^{[1
]}

Cao, Han ^{[1
]}

Zhang, Jiayi ^{[2
]}

Xue, Feng ^{[1
]}

Hu, Mengyan ^{[2
]}

Xia, Yuhan ^{[1
]}

Pan, Meng ^{[2
]}

Chen, Lihong ^{[2
]}

Zheng, Jie ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Rui Jin Hosp, Lab Dermatoimmunol, Sch Med, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China

[2] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Dermatol, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China

[3] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Ctr Biosafety Mega Sci, Shanghai, Peoples R China

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 90卷 / 05期

基金：

中国国家自然科学基金;

关键词：

IL-17A blocker; ixekizumab treatment-associated urticaria; mast cell; psoriasis; psoriasis relapse; DEGRANULATION; MODERATE; PHASE-3;

D O I：

10.1016/j.jaad.2024.01.014

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background: Mast cell degranulation plays a pivotal role in urticaria and is also an early histologic characteristic of psoriasis. However, whether the activation of mast cells contributes to psoriasis recurrence after discontinuation of interleukin (IL) -17A blockers remains unclear. Objective: To investigate the role of mast cells in ixekizumab treatment -associated urticaria (ITAUR) and assess the effect of urticaria eruption on psoriasis relapse. Methods: A retrospective analysis was performed on biopsies of patients who experienced psoriasis relapse after discontinuation of ixekizumab. Transcriptomic and histopathologic features were assessed. Patterns were compared between patients with ITAUR and nonurticaria (NUR) as well as psoriasis -like mice with mast cell activation or inactivation. Results: Patients with ITAUR experienced early relapse compared with NUR group after treatment withdrawal. Transcriptomic and histopathologic analyses revealed that patients with ITAUR had an elevated proportion of mast cells in resolved skin. Especially, the proportion of IL -17A + mast cells was inversely correlated with the duration of remission. Limitations: The mechanism of mast cell activation in ITAUR has not been precisely elucidated. Conclusion: Ixekizumab treatment increases IL -17A + mast cells in lesions of ITAUR, which is associated with early psoriasis relapse after ixekizumab withdrawal. ( J Am Acad Dermatol 2024;90:970-6.)

引用

页码：970 / 976

页数：7

共 31 条

[1] MAST-CELL DE-GRANULATION IN THE EVOLUTION OF ACUTE ERUPTIVE GUTTATE PSORIASIS-VULGARIS [J].